sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
28-Aug-2014 01:25
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 126-150 out of 888.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>

Public Release: 5-Jun-2014
UH chemist's work could impact disease management, treatments
A University of Houston chemist hopes his work will one day impact the treatment of such diseases as cancer and malaria by better understanding how molecules react and how atoms come together to form bonds. Jeremy May, an assistant professor of chemistry at UH, received a five-year, $600,000 National Science Foundation CAREER Award to develop synthetic strategies to increase the efficiency and yields of chemical reactions.
National Science Foundation

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston

Public Release: 4-Jun-2014
Proceedings of the National Academy of Sciences
Hemorrhagic fevers can be caused by body's antiviral interferon response
Virologists and immunologists at The Scripps Research Institute have found a major clue to the mystery of 'hemorrhagic fever' syndromes. The team showed that Interferon Type I immune proteins are key drivers of a viral syndrome in mice that closely mimics human hemorrhagic fevers.
National Institutes of Health

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 4-Jun-2014
Shared mission of health equity joins NYU GIPH and HealthRight International
A unique collaboration between New York University's Global Institute of Public Health (NYU GIPH) and the global health and human rights organization HealthRight International, Inc. was announced today by Robert Berne, New York University executive vice president for health, Dr. Cheryl Healton, dean of Global Public Health and director of NYU GIPH, and Dr. Peter Navario, HealthRight executive director. NYU GIPH and HealthRight will collaborate on global health programming, research, curricula, work-study placements, and internships.

Contact: Robert Polner
robert.polner@nyu.edu
212-998-2337
New York University

Public Release: 3-Jun-2014
Global health grant from the Bill & Melinda Gates Foundation awarded to the University of Surrey
The University of Surrey announced today that it has been awarded a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. With the grant, Professor Johnjoe McFadden will aim to revolutionize the control of tuberculosis by modifying the vaccine and designing a new test for the human form of the disease.
Bill & Melinda Gates Foundation

Contact: Peter La
p.la@surrey.ac.uk
01-483-689-191
University of Surrey

Public Release: 3-Jun-2014
Hepatology
Liver cancer vaccine effective in mice
Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
NIH/National Cancer Institute

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 30-May-2014
UTHealth's Anil Kulkarni awarded Fulbright Scholarship
Anil Kulkarni, MSc, Ph.D., professor in the Department of Surgery at The University of Texas Health Science Center at Houston Medical School, was awarded a highly competitive Fulbright-Nehru Scholarship Award for Academic and Professional Experience to travel to India this fall to teach immunonutrition and functional foods in the global health era.
Fulbright-Nehru Scholarship Award for Academic and Professional Experience

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 28-May-2014
Sexually Transmitted Infections
In Africa, STI testing could boost HIV prevention
Sexually transmitted infections can make HIV transmission more likely, undermining the prevention benefit of HIV treatment. A new study of HIV-positive patients in Cape Town, South Africa, found that the prevalence of such co-infections was much higher before beginning HIV treatment. Testing for and treating STIs and HIV together could therefore improve HIV prevention.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 28-May-2014
Journal of Tropical Medicine
Experimental trial represents promising step toward universal antidote for snakebite
A team of researchers, led by Dr. Matthew Lewin of the California Academy of Sciences and Dr. Stephen P. Samuel of Trinity College Dublin, Ireland has taken another promising step toward developing a universal antidote for snakebite. The results of this pilot study were recently published in the Journal of Tropical Medicine. These findings support the team's idea that providing fast, accessible, and easy-to-administer treatment can increase survival rates in victims of venomous snakebite.

Contact: Kelly Mendez
kmendez@calacademy.org
415-379-5133
California Academy of Sciences

Public Release: 28-May-2014
Lancet
Nearly one-third of the world's population is obese or overweight, new data show
Today, 2.1 billion people -- nearly 30 percent of the world's population -- are either obese or overweight, according to a new, first-of-its kind analysis of trend data from 188 countries. The rise in global obesity rates over the last three decades has been substantial and widespread, presenting a major public health epidemic in both the developed and the developing world.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 27-May-2014
PLOS Medicine
Barriers to HIV testing in older children
Concerns about guardianship and privacy can discourage clinics from testing children for HIV, according to new research from Zimbabwe published this week in PLOS Medicine. The results of the study, by Rashida A. Ferrand of the London School of Hygiene & Tropical Medicine and colleagues, provide much-needed information on how to improve care of this vulnerable population.
Wellcome Trust

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 23-May-2014
Rising star uses paper to tackle food-borne diseases
UAlberta post-doc's idea for paper-based diagnostic tool earns place among Grand Challenges Canada's Stars in Global Health.
Grand Challenges Canada

Contact: Bryan Alary
bryan.alary@ualberta.ca
780-492-0436
University of Alberta

Public Release: 22-May-2014
Science
Scientists identify potential vaccine candidate for pediatric malaria
Researchers have identified a substance, or antigen, that generates antibodies that can hinder the ability of malaria parasites to multiply, which may protect against severe malaria infection. The antigen, known as PfSEA-1, was associated with reduced parasite levels among children and adults in malaria-endemic areas.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 22-May-2014
The Royal Society: Antimicrobial resistance -- addressing the threat to global health
Nature
Antibiotic crisis needs united global response, experts say
Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, say experts from the University of Edinburgh and the Wellcome Trust.

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh

Public Release: 22-May-2014
Science
RI Hospital researcher and colleagues discover protein that may lead to malaria vaccine
Rhode Island Hospital researchers have discovered a protein that is essential for malaria-causing parasites to escape from inside red blood cells. This protein could lead to the development of a vaccine that would prevent the progression of Plasmodium falciparum malaria, which kills one child every 15 seconds each year in Sub-Saharan Africa and Southeast Asia, according to new research by Jonathan Kurtis, M.D., Ph.D., and colleagues.
National Institutes of Health, Bill and Melinda Gates Foundation

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan

Public Release: 21-May-2014
Trends in Parasitology
Scientist uncovers links connecting environmental changes with spike in infectious disease
Smithsonian scientist Bert Van Bocxlaer and a team of researchers revealed that anthropogenic changes in Africa's Lake Malaŵi are a driving force behind the increase of urogenital schistosomiasis, a debilitating disease caused by parasitic flatworms. In some villages along Lake Malaŵi, 73 percent of people and up to 94 percent of schoolchildren are infected. The research suggests the spike in infection is linked to an increase in human populations and agricultural activities near Lake Malaŵi.

Contact: Kathryn Sabella
sabellak@si.edu
202-633-2950
Smithsonian

Public Release: 16-May-2014
Cancer Epidemiology, Biomarkers & Prevention
Analysis finds wide variation in lung cancer rates globally
The only recent comprehensive analysis of lung cancer rates for women around the world finds lung cancer rates are dropping in young women in many regions of the globe, pointing to the success of tobacco control efforts.
American Cancer Society

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 15-May-2014
Cell Reports
Protein sharpens salmonella needle for attack
A tiny nanoscale syringe is Salmonella's weapon. Using this, the pathogen injects its molecular agents into the host cells and manipulates them to its own advantage. Scientists at the Biozentrum of the University of Basel demonstrate in their current publication in Cell Reports that a much investigated protein, which plays a role in Salmonella metabolism, is required to activate these needles and makes the replication and spread of Salmonella throughout the whole body possible.

Contact: Katrin Bühler
Katrin.Buehler@unibas.ch
University of Basel

Public Release: 15-May-2014
PLOS Pathogens
How some trypanosomes cause sleeping sickness while others don't
Trypanosome parasites transmitted by tsetse flies cause devastating diseases in humans and livestock. Different subspecies infect different hosts: Trypanosoma brucei brucei infects cattle but is non-infectious to humans, whereas T. b. gambiense and T. b. rhodesiense cause sleeping sickness in humans. A study published on May 15th in PLOS Pathogens reveals how humans can fight off some trypanosomes but not others.

Contact: Sam Alsford
press@lshtm.ac.uk
44-020-792-72802
PLOS

Public Release: 14-May-2014
Cochrane Library
Zinc supplementation boosts immune system in children, Cochrane Review finds
Zinc supplements reduce diarrhoea and other infections in malnourished children, and may prevent death, according to a new study published in The Cochrane Library. The study is the first Cochrane systematic review to focus on zinc as a means to prevent childhood death, including deaths caused by diarrhea, one of the biggest killers of under-fives.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
201-748-6358
Wiley

Public Release: 14-May-2014
Science Translational Medicine
Hitting a moving target
A vaccine or other therapy directed at a single site on a surface protein of HIV could in principle neutralize nearly all strains of the virus -- thanks to the diversity of targets the site presents to the human immune system.
International AIDS Vaccine Initiative, National Institutes of Health, Canadian Institutes of Health, Gates Foundation

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 13-May-2014
Annals of Anthropological Practice
Understanding the 1918 flu pandemic can aid in better infectious disease response
The 1918 Flu Pandemic infected over 500 million people, killing at least 50 million. Now, a researcher at the University of Missouri has analyzed the pandemic in two remote regions of North America, finding that despite their geographical divide, both regions had environmental, nutritional and economic factors that influenced morbidity during the pandemic. Findings from the research could help improve current health policies.

Contact: Jeff Sossamon
sossamonj@missouri.edu
573-882-3346
University of Missouri-Columbia

Public Release: 13-May-2014
PLOS Medicine
Pretreatment snack improves uptake of schistosomiasis treatment in schoolchildren
Provision of a snack before mass treatment of schistosomiasis with praziquantel leads to increased uptake of treatment in school-aged children in Uganda, according to a study published in this week's PLOS Medicine. Simon Muhumuza and colleagues from Makerere University, Kampala, Uganda found that 93.9 percent of children reported taking praziquantel in schools that offered a snack before treatment compared with 78.7 percent of children in schools that did not offer a snack.
Danish Ministry of Foreign Affairs

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 12-May-2014
Vaccine
PSC, Hopkins computer model helps Benin vaccinate more kids at lower cost
Researchers from Pittsburgh Supercomputing Center, the University of Pittsburgh School of Engineering and the Johns Hopkins Bloomberg School of Public Health have used HERMES, their modeling software, to help the Republic of Benin in West Africa determine how to bring more lifesaving vaccines to its children. Results from the HERMES model have helped the country enact some initial changes in their vaccine delivery system, which may lead to further changes nationwide.

Contact: Ken Chiacchia
chiacchi@psc.edu
412-268-5869
Pittsburgh Supercomputing Center

Public Release: 12-May-2014
Proceedings of the National Academy of Sciences
'Shocking' Stanford video reveals the surprising truth about cell wall growth
For a century biologists have thought they understood how the gooey growth that occurs inside cells caused their protective outer walls to expand. Now, using new microscopic video techniques, Stanford researchers have captured the visual evidence to prove the prevailing wisdom wrong.
National Institutes of Health

Contact: Tom Abate
tabate@stanford.edu
650-736-2245
Stanford School of Engineering

Public Release: 8-May-2014
Molecular & Cellular Proteomics
Hepatitis C virus: How viral proteins interact in human cells
Scientists at the Helmholtz Zentrum München have for the first time decrypted the interaction network of hepatitis C virus proteins in living human cells. Their findings will contribute to a better understanding of the mechanisms behind inflammatory liver disease caused by hepatitis C viruses and open up new avenues for therapy development. The results are published in the specialist journal Molecular & Cellular Proteomics.

Contact: Press Office
presse@helmholtz-muenchen.de
49-893-187-2238
Helmholtz Zentrum München - German Research Center for Environmental Health

Showing releases 126-150 out of 888.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>